home All News open_in_new Full Article

Sandoz reports Q1 2025 net sales in line with company expectations; full

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Q1 2025 net sales of USD 2,480 million  up by 3% in constant currencies (cc); stable in USD up by 5%[1] at a comparable growth rate (CGR), when adjusted for impact of 2024 acquisition of US biosimilar Cimerli® (ranibizumab) and 2024 divestment […]


today 16 h. ago attach_file Economics

attach_file Economics
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Other
attach_file Other
attach_file Other
attach_file Economics
attach_file Other
attach_file Other
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Society
attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Economics
attach_file Economics


ID: 715267943
Add Watch Country

arrow_drop_down